Clin2
NCT06937294Possibly a fitRecruiting

Metformin for diabetes from chronic pancreatitis

Chronic Pancreatitis

Treatments studied

Part of Digestive system clinical trials.

This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
58 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with chronic pancreatitis.
  • Your diabetes was diagnosed at least 3 months after your pancreatitis diagnosis.
  • You have never taken any diabetes medication, or you stopped taking it at least 8 weeks ago.
  • Your HbA1c level is between 7.5% and 9.0%.
  • Your BMI is above 18.5.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07670871Not yet recruiting
Pancreas and diabetes study for adults at risk or newly diagnosed

This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.

NCT06826729Not yet recruiting
Blood sugar and hormone changes in diabetes from chronic pancreatitis

This study looks at how blood sugar levels and certain hormones change in people with diabetes caused by chronic pancreatitis. It may help doctors better understand and manage this condition, so the findings could improve care for others like you.

NCT07314489Recruiting· Early Phase 1
Glucose and enzyme function in chronic pancreatitis

This study looks at how chronic pancreatitis affects blood sugar and digestion. It tests if your body makes enough enzymes and how your sugar control changes over time.

Shanghai, Shanghai Municipality
NCT06729996Recruiting· Phase 2
Comparing two diabetes medicines for pancreatitis-related diabetes

This trial tests whether pioglitazone or empagliflozin is better at managing diabetes caused by chronic or recurrent pancreatitis. You will take one of these pills daily for 6 months and track your blood sugar and ketones at home. The goal is to find a safer, more effective treatment for this type of diabetes.

Rochester, Minnesota
NCT06932874Recruiting· Phase 4
Metformin for diabetes with heart disease

This trial tests a long-acting metformin pill in people with both type 2 diabetes and coronary heart disease. It aims to see if metformin can safely help control blood sugar in this specific group.

Beijing, Beijing Municipality
NCT05197920Recruiting
Study of diabetes after acute pancreatitis

This study looks at why some people develop diabetes after acute pancreatitis and how that process works in the body. It may help doctors better predict risk and tailor care for people recovering from pancreatitis.

Los Angeles, California

Hear when a new Chronic Pancreatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.